GI INNOVATION INC has a total of 38 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are GENEXINE INC, ARIZEKE PHARMACEUTICALS INC and THERAVAC PHARMACEUTICALS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Brazil | 3 | |
#5 | Canada | 3 | |
#6 | Chile | 3 | |
#7 | China | 3 | |
#8 | EPO (European Patent Office) | 3 | |
#9 | Israel | 3 | |
#10 | Peru | 3 | |
#11 | Singapore | 3 | |
#12 | Taiwan | 2 | |
#13 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Foods | |
#6 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Sung Young Chul | 15 |
#2 | Yang Zungyoon | 15 |
#3 | Jang Myoung Ho | 11 |
#4 | Jang Myung Ho | 10 |
#5 | Lee Kyungwha | 2 |
#6 | Jang Myoung-Ho | 2 |
#7 | Sung Young-Chul | 2 |
#8 | Jang Myung-Ho | 2 |
#9 | Yang Zung-Yoon | 2 |
#10 | Yang Bo-Gie | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021006599A1 | Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit of ige fc receptor, and pharmaceutical composition comprising same | |
AU2019343850A1 | Fusion protein comprising IL-2 protein and CD80 protein, and use thereof | |
WO2021006375A1 | Polypeptide dimer containing high amount of sialic acid and including extracellular domain of alpha subunit of ige fc receptor, and pharmaceutical composition containing same | |
EP3738599A1 | Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof | |
BR112020013805A2 | extracellular domain of the alpha subunit of the ige fc receptor, pharmaceutical composition comprising the same and method for producing the same |